Data coverage, completeness and provenance for EMYRIA LIMITED in the Stock Market API — Health Care · Health Information Services.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0390 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0390 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0410 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0390 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0390 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/EMD/prices · Price parameters and adjustment semantics
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-RX9) and proprietary MDMA analogues, as well as provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the expand Emyria's MDMA analogue drug development program. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Subiaco, Australia.
Website: https://emyria.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/EMD/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 31 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 30 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/EMD
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/EMD/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/EMD/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/EMD/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/EMD/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/EMD
Free tier — instant API key. Built for AI agents.